Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 03, 2026
Space Exploration Technologies Corp. (SPCX) Eyes Recovery to $150 After -28% From Nasdaq Debut

Space Exploration Technologies Corp. (SPCX) Eyes Recovery to $150 After -28% From Nasdaq Debut

Key Takeaways

  • Space Exploration Technologies Corp. (SPCX) closed at $108.37 on July 31, 2026, roughly 28% below the $150 level that marked its Nasdaq opening trade on June 12.
  • The stock has fallen approximately 52% from its all-time high of $225.64 and now trades about 20% below its IPO price of $135.
  • A return to $150 would require a gain of roughly 38% from current levels, a move that Wall Street analysts broadly consider achievable given a consensus price target of $236.71.
  • Bullish catalysts include Starlink's growing subscriber base, new AI compute contracts, and the long-term potential of Starship, while bearish risks center on an August 6 lockup expiration, ongoing net losses, and an elevated price-to-sales multiple.
  • Key support sits near the $107–$108 zone, while $150 represents both a psychological round number and the stock's first public trade — making it a meaningful recovery milestone.

Why the $150 Level Holds Special Meaning

SpaceX made history on June 12, 2026, with the largest initial public offering (IPO) ever recorded, raising $75 billion at a fixed price of $135 per share. When SPCX opened for trading on the Nasdaq that morning, the first print was $150 — a level that instantly became embedded in the market's memory. Shares closed their debut session at $160.95 and surged as high as $225.64 within days. Less than two months later, the stock has surrendered all of those early gains, closing at $108.37 on July 31 and touching an intraday low of $107.01 during the week.

For many investors, $150 is not just a round number. It represents the initial public market validation of SpaceX's enormous private-market valuation. Reclaiming that level would signal that the post-IPO sell-off has fully reversed and that buyer conviction has returned. It is also a price mentioned repeatedly in analyst notes as a logical first upside target on any sustained recovery.

Current Market Position: What Sent SPCX Below Its IPO Price

SpaceX operates across three segments: Space (launch services using Falcon 9 and Falcon Heavy rockets), Connectivity (the Starlink satellite internet business), and AI (following the acquisition of xAI, which includes the Grok large language model and the Colossus data center). The company generated trailing twelve-month revenue of approximately $19.3 billion, reflecting 33% year-over-year growth, but remains deeply unprofitable with a net loss of $9.36 billion and negative earnings per share (EPS) of -$2.94.

Several converging pressures have pushed SPCX lower. The stock's tiny public float — only about 4% to 5% of total shares outstanding were sold in the IPO — amplified both the initial rally and the subsequent decline. The impending August 4 earnings report, the company's first as a public entity, has introduced uncertainty. Even more significant is the August 6 lockup expiration, which could release up to 911.5 million shares held by employees and early investors into the market. The all-stock $60 billion acquisition of Cursor has added dilution concerns. Meanwhile, Starship's 13th test flight produced mixed results, reminding investors that the company's most ambitious engineering milestones remain works in progress. I also checked this using Tickeron’s AI Pattern Search Engine to see how the post-IPO pattern compares to similar debut situations.

What Could Drive SPCX Back to $150

A return to $150 is far from theoretical. The consensus analyst price target of $236.71 — based on 34 analysts — implies that Wall Street expects SPCX to trade well above $150 within the next twelve months. Several tangible catalysts could fuel such a recovery.

First, Starlink continues to scale. The satellite internet business generated $11.4 billion in revenue in 2025 and served approximately 10.3 million subscribers across 164 countries as of March 2026. While average revenue per user has compressed, the sheer pace of subscriber growth provides a recurring revenue foundation that few competitors can match. Second, SpaceX's AI compute segment is gaining traction. The company signed a contract with Anthropic worth $1.25 billion per month through May 2029 for compute capacity. Third, SpaceX's dominant position in commercial launch — it captured 82% of the U.S. commercial launch market in 2025 — gives it a wide economic moat that supports long-term revenue visibility. The U.S. Space Force recently awarded SpaceX a $1.6 billion contract for 18 Falcon 9 launches through 2027.

Additionally, prominent institutional investors continue to express conviction. Cathie Wood's ARK Invest has been buying SPCX shares throughout the decline. Billionaire investor Ron Baron, who holds one of the largest SpaceX stakes among public fund managers, has predicted the company could eventually be worth trillions more than its current market capitalization.

What Could Prevent the Move

The obstacles are substantial. The August 6 lockup expiration is the most immediate concern. Even if only a fraction of the 911.5 million newly eligible shares are sold, the additional supply could overwhelm demand in a market where the float is already thin. More lockup expirations are scheduled in the months ahead, with Elon Musk's own shares not fully unlocking until mid-2027.

Valuation remains a persistent headwind. At $108.37, SPCX still trades at roughly 74 times trailing sales, an exceptionally rich multiple for a company that is not yet profitable. Morningstar, which published a pre-IPO fair value estimate of $63 per share, has maintained its skeptical stance, arguing that the market is pricing in unproven outcomes across Starship, orbital AI data centers, and interplanetary ambitions.

Competition is intensifying. AMZN subsidiary Project Kuiper seeks FCC approval to launch over 5,000 broadband satellites, directly challenging Starlink's market. In the AI space, xAI's Grok model trails MSFT-backed OpenAI's ChatGPT and Anthropic's Claude in both user metrics and market mindshare, raising questions about the segment's ability to drive outsized revenue growth.

Analyst Opinions and Price Targets

The analyst community is broadly constructive but far from unanimous. Of the 34 analysts covering SPCX, the consensus rating is "Buy" with an average twelve-month price target of $236.71 — more than double the current price. Morgan Stanley's Adam Jonas holds an Overweight rating with a $300 target, arguing that at current levels the market is assigning almost no value to SpaceX's AI business. Goldman Sachs, JPMorgan, Bank of America, and Deutsche Bank have all issued Buy-equivalent ratings with targets clustered between $200 and $255. Cantor Fitzgerald recently reaffirmed a $246 target ahead of earnings.

On the more cautious side, CFRA initiated coverage with a Sell rating and a $115 target, while MoffettNathanson set the Street-low target at $131 with a Neutral rating. Morningstar's fair value estimate of $62 remains the most bearish published figure. The wide dispersion — from $62 to $800 — reflects genuine uncertainty about which parts of SpaceX's ambitious roadmap will materialize and when.

Technical Levels That Matter

SPCX remains in a clear downtrend, with its five-day and twenty-day moving averages both sloping lower. The $107–$108 zone has emerged as immediate support, with the psychologically significant $100 level representing the next downside marker if that floor gives way. On the upside, SPCX must first recover the $112–$114 area, where the 50-period exponential moving average sits, before mounting any credible challenge to higher levels. A move through $120 would likely attract momentum-driven buyers. The $135 IPO price then becomes the next major hurdle before $150 comes into view. A sustained break above $150 would mark the stock's first higher high since mid-June and would meaningfully shift the technical narrative from bearish to neutral or improving.

Final Assessment

A return to $150 for SpaceX stock is a realistic medium-term scenario, but it is unlikely to happen without clearing several near-term hurdles. The strongest arguments in favor are the overwhelming Wall Street consensus that SPCX is undervalued at current levels, Starlink's expanding subscriber base, growing AI compute revenue, and SpaceX's dominant competitive position in launch services. The most formidable obstacles are the August 6 lockup expiration, the company's lack of profitability, an elevated valuation multiple, and technical damage that will take time to repair. Investors should monitor the upcoming earnings report on August 4 for clarity on revenue trajectory and margin trends, observe how the market absorbs the post-lockup share supply, and watch whether SPCX can establish a sustainable base above the $107–$108 support zone. In a best-case scenario, strong earnings and manageable insider selling could pave the way for a gradual recovery toward $135 and then $150 over the coming quarters. In a more challenging scenario, additional selling pressure could test the $100 level before any meaningful rebound takes hold.

AI Daily Buy/Sell Signals for Post-IPO Stocks

In my own research on volatile names like SPCX, I have turned to Tickeron's AI Daily Buy/Sell Signals to monitor momentum shifts and generate timely alerts. The tool scans thousands of stocks and ETFs using AI to produce Buy, Sell, or Hold signals based on technical patterns and evolving conditions. It adds a useful layer of data-driven insight that complements fundamental work, especially during periods of high uncertainty such as lockup expirations and first earnings reports.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SPCX

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 43.01B. The market cap for tickers in the group ranges from 4.49 to 1.86T. SPCX holds the highest valuation in this group at 1.86T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was 4%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 6%. DFSC experienced the highest price growth at 88%, while EVTL experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was 92% and the average quarterly volume growth was 109%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 66
Price Growth Rating: 51
SMR Rating: 78
Profit Risk Rating: 71
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Profile
Details
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.